IL-18 代谢重编程表达 CAR 的自然杀伤 T 细胞并增强其抗肿瘤活性
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity.
76.4分
★★★★☆
站内排序·非疗效
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity.
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody.
MEMBER ACCOUNT
登录成功会直接打开下一页。